MCOV B — Medicover AB Income Statement
0.000.00%
Last trade - 00:00- SEK29.06bn
- SEK40.96bn
- €1.75bn
- 78
- 15
- 98
- 72
Annual income statement for Medicover AB, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 844 | 998 | 1,377 | 1,510 | 1,746 |
| Cost of Revenue | |||||
| Gross Profit | 207 | 264 | 395 | 340 | 359 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 798 | 937 | 1,218 | 1,455 | 1,677 |
| Operating Profit | 46.5 | 61.3 | 159 | 55.5 | 69.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 33.3 | 37.3 | 144 | 19.8 | 23.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 24.7 | 27.3 | 107 | 14 | 18.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 22.5 | 25.8 | 102 | 12.1 | 17.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 22.5 | 25.8 | 102 | 12.1 | 17.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.197 | 0.255 | 0.737 | 0.146 | 0.08 |
| Dividends per Share |